• Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
Wednesday, November 18, 2026
No Result
View All Result
Subscribe Now
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
The Insight Post
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
No Result
View All Result
No Result
View All Result
Home Science

We may soon have a working HIV vaccine

by Theinsightpost
June 25, 2024
in Science
0 0
0
We may soon have a working HIV vaccine

Globally, almost 40 million people worldwide are living with HIV. Over 150,000 more people get it every year. Although the incidence is slowly decreasing, HIV remains one of the most devastating pandemics affecting mankind. Now, a new vaccine promises to turn the tide against the disease.

AI-generated image of an anti-HIV vaccine.

A step closer to prevention

The trial was carried out by pharmaceutical company Gilead, and it was a Phase 3 trial assessing the efficacy and safety of the vaccine called lenacapavir. The vaccine is administered twice yearly and aims to prevent HIV infections.

The trial involved over 5,300 cisgender women and adolescent girls aged 16-25 across sites in South Africa and Uganda, two countries with a high incidence of HIV.

Participants were randomized into three groups: those receiving twice-yearly lenacapavir, daily oral Descovy, (emtricitabine and tenofovir alafenamide), and daily oral Truvada. The trial’s design avoided a placebo group due to ethical considerations. Essentially, because some prevention already exists, it’s not ethical to compare the new vaccine to a placebo. So, instead, the researchers used background HIV incidence (bHIV) as the primary comparator and Truvada as a secondary comparator.

The results were striking. There were zero reports of HIV infections among the 2,134 women in the lenacapavir group, compared to 16 infections among the 1,068 women in the Truvada group. These findings establish the superiority of lenacapavir over both bHIV and Truvada, with a statistical significance of p<0.0001 for both endpoints.

“With zero infections and 100% efficacy, twice-yearly lenacapavir has demonstrated its potential as an important new tool to help prevent HIV infections,” said Merdad Parsey, MD, PhD, Chief Medical Officer, Gilead Sciences. “We look forward to additional results from the ongoing PURPOSE clinical program and continuing toward our goal of helping to end the HIV epidemic for everyone, everywhere.”

Hope in the fight against HIV

Analysts interpreted the vaccine’s results as a “near best-case” scenario for the company. The results were better than even Gilead expected. No large-scale HIV study has had zero infections until now, raising new hope for infection prevention. The fact that you only need two vaccine doses, compared to daily prevention, also makes lenacapavir far more attractive (and cheaper).

To make matters even better, the vaccine may be in use relatively quickly.

Lenacapavir is already approved under the brand name Sunlenca as a treatment for HIV that’s resistant to other medicines, although it’s not a big seller for Gilead. All that’s needed would be a change in the regimen.

“Twice-yearly lenacapavir for PrEP, if approved, could provide a critical new choice for HIV prevention that fits into the lives of many people who could benefit from PrEP around the world—especially cisgender women,” said Linda-Gail Bekker, Director of the Desmond Tutu HIV Center at the University of Cape Town, South Africa, and past President of the International AIDS Society.

“While we know traditional HIV prevention options are highly effective when taken as prescribed, twice-yearly lenacapavir for PrEP could help address the stigma and discrimination some people may face when taking or storing oral PrEP pills, as well as potentially help increase PrEP adherence and persistence given its twice-yearly dosing schedule.”

However, the company notes that the use of lenacapavir for the prevention of HIV in women is “investigational”. The treatment has “not been determined to be safe or efficacious” and “is not approved anywhere globally”.

Nevertheless, the company expects results from another trial this year (or in 2025). The trial is assessing twice-yearly lenacapavir for HIV prevention among cisgender men who have sex with men, transgender men, transgender women and non-binary individuals who have sex with partners assigned male at birth in Argentina, Brazil, Mexico, Peru, South Africa, Thailand and the United States. 

Then, after this trial is also concluded, Gilead will pursue a regulatory filing, if the vaccine is found to be safe and effective for multiple populations and communities in need of HIV prevention options.

This biannual injectable not only promises a more convenient and adherent-friendly option compared to daily prevention methods but also represents a potential turning point in HIV prevention. As Gilead awaits further results from ongoing trials and prepares for regulatory filings, the future of HIV prevention looks increasingly optimistic, bringing the world closer to ending this devastating epidemic.

Thanks for your feedback!

ShareTweetSend
Previous Post

Jay Slater’s distraught mum reveals she’s ‘barely slept’ as missing teen’s ex-girlfriend & pals join search in Tenerife

Next Post

Protesters in Kenya are tired of double standards, and it will take more than bullets to stand them down | World News

Related News

Groundbreaking Electric Comb Promises Hair Regrowth in Mice Within Four Weeks, Paving the Way for Future Hair-Loss Solutions
Science

Groundbreaking Electric Comb Promises Hair Regrowth in Mice Within Four Weeks, Paving the Way for Future Hair-Loss Solutions

November 18, 2026
Miniature LSD Doses Administered in Rapid Succession Show Antidepressant Potential in Mice: Exploring the Impact of Timing vs. Tolerance
Science

Miniature LSD Doses Administered in Rapid Succession Show Antidepressant Potential in Mice: Exploring the Impact of Timing vs. Tolerance

November 14, 2026
Investigation Underway: Experts Seek Answers Behind Sudden Brooklyn Building Collapse
Science

Investigation Underway: Experts Seek Answers Behind Sudden Brooklyn Building Collapse

November 12, 2026
Preserve the Unseen: The Essential Role of Parasites in Ecosystems
Science

Preserve the Unseen: The Essential Role of Parasites in Ecosystems

November 11, 2026
Next Post
Protesters in Kenya are tired of double standards, and it will take more than bullets to stand them down | World News

Protesters in Kenya are tired of double standards, and it will take more than bullets to stand them down | World News

Discussion about this post

Subscribe To Our Newsletters

    Customer Support


    1251 Wilcrest Drive
    Houston, Texas
    77042 USA
    Call-832.795.1420
    e-mail – news@theinsightpost.com

    Subscribe To Our Newsletters

      Categories

      • Africa
      • Africa-East
      • African Sports
      • American Sports
      • Arts
      • Asia
      • Australia
      • Business
      • Business Asia
      • Business- Africa
      • Canada
      • Defense
      • Education
      • Egypt
      • Energy
      • Entertainment
      • Europe
      • European Soccer
      • Finance
      • Germany
      • Ghana
      • Health
      • Insight
      • International
      • Investing
      • Japan
      • Latest Headlines
      • Life & Living
      • Markets
      • Mobile
      • Movies
      • New Zealand
      • Nigeria
      • Politics
      • Scholarships
      • Science
      • South Africa
      • South America
      • Sports
      • Tech
      • Travel
      • Travel-Africa
      • UK
      • USA
      • Weather
      • World
      No Result
      View All Result

      Recent News

      Expert Challenges Obama-Era Housing First Initiative Following LAHSA Budget Reductions

      Expert Challenges Obama-Era Housing First Initiative Following LAHSA Budget Reductions

      November 18, 2026
      Alphabet’s Valuation Estimated at 1 Through Discounted Cash Flow Analysis

      Alphabet’s Valuation Estimated at $291 Through Discounted Cash Flow Analysis

      November 18, 2026
      Crimea Bridge Targeted in Renewed Assault, Reports Russian Governor

      Crimea Bridge Targeted in Renewed Assault, Reports Russian Governor

      November 18, 2026
      FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

      FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

      November 18, 2026
      • Home
      • Advertise With Us
      • About Us
      • Corporate
      • Consumer Rewards
      • Forum
      • Privacy Policy
      • Social Trends

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      Welcome Back!

      Login to your account below

      Forgotten Password?

      Retrieve your password

      Please enter your username or email address to reset your password.

      Log In

      Add New Playlist

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in .

      No Result
      View All Result
      • Home
      • Insight
      • Blog
      • Business
      • Entertainment
      • Health
      • Politics
      • Shop
        • Gift Shop
        • Value Shop
        • Store
        • Bargain Shop
        • Discount
      • Sports
      • Tech
      • Travel
      • USA
      • Video
      • World
        • Asia
        • Africa
        • South America
        • North America
        • Europe
        • Oceania

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      The Insight Post
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      Cookie Policy

      More information about our Cookie Policy